Genotyping of BRCA1, BRCA2, p53, CDKN2A, MLH1 and MSH2 genes in a male patient with secondary breast cancer

Vodusek, Ana; Novakovic, Srdjan; Stegel, Vida; Jereb, Berta

doi:10.2478/v10019-011-0031-6

Abstract

Background. Some tumour suppressor genes (BRCA2) and mismatch repair genes (MSH2, MLH1) are correlated with an increased risk for male breast cancer.

Case report. Our patient developed secondary breast cancer after the treatment for Hodgkin's disease in childhood. DNA was isolated from the patients' blood and screened for mutations, polymorphisms and variants in BRCA1, BRCA2, p53, CDKN2A, MLH1 and MSH2 genes. We found no mutations but common polymorphisms, and three variants in mismatch repair genes.

Conclusions. Nucleotide variants c.2006-6T>C and p.G322D in MSH2 might be correlated with male breast cancer.

References

Jazbec J, Todorovski L, Jereb B. Classification tree analysis of second neoplasms in survivors of childhood cancer. BMC Cancer 2007; 7: 1-6.10.1186/1471-2407-7-27
Search in Google Scholar
Metayer C, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 2000; 18: 2435-43.10.1200/JCO.2000.18.12.2435
Search in Google Scholar
Boussen H, Kochbati L, Besbes M, Dhiab T, Makhlouf R, Jerbi G, et al. [Male secondary breast cancer after treatment for Hodgkin's disease. Case report and review of the literature]. [French]. Cancer Radiother 2000; 4: 465-8.10.1016/S1278-3218(00)00018-4
Search in Google Scholar
Ozet A, Yavuz AA, Kömürcü S, Oztürk B, Safali M, Arpaci F, et al. Bilateral male breast cancer and prostate cancer: a case report. Jpn J Clin Oncol 2000; 30: 188-90.10.1093/jjco/hyd05010830988
Search in Google Scholar
Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 20-26.10.1158/1055-9965.20.14.1
Search in Google Scholar
Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern Med 2002; 137: 678-87.10.7326/0003-4819-137-8-200210150-0001312379069
Search in Google Scholar
Leinung S, Horn LC, Backe J. [Male breast cancer: history, epidemiology, genetic and histopathology]. [German]. Zentralbl Chir 2007; 132: 379-85.10.1055/s-2007-98126017907078
Search in Google Scholar
Murata H, Khattar NH, Gu L, Li GM. Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer. Cancer Lett 2005; 223: 143-50.10.1016/j.canlet.2004.09.03915890247
Search in Google Scholar
Latz D, Alfrink M, Nassar N, Beyerle C. Breast cancer in a male patient after treatment of acute lymphoblastic leukemia including total body irradiation and bone marrow transplantation. Onkologie 2004; 27: 477-9.
Search in Google Scholar
Zebic-Sinkovec M, Kadivec M, Podobnik G, Skof E, Snoj M. Mammographycally occult high grade ductal carcinoma in situ (DCIS) as second primary breast cancer, detected with MRI: a case report. Radiol Oncol 2010; 44: 228-31.10.2478/v10019-010-0033-9342370622933920
Search in Google Scholar
Thomas DB, Rosenblatt K, Jimenez LM, McTiernan A, Stalsberg H, Stemhagen A, et al. Ionizing radiation and breast cancer in men (United States). Cancer Causes and Control 1994; 5: 9-14.10.1007/BF018307218123783
Search in Google Scholar
Eeles RA. Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2000; 2: 283-90.10.1186/bcr7013878911250722
Search in Google Scholar
Malkin D. The role of p53 in human cancer. J Neurooncol 2001; 51: 231-43.10.1023/A:1010636426860
Search in Google Scholar
Zager V, Cemazar M, Hreljac I, Lah TT, Sersa G, Filipic M. Development of human cell biosensor system for genotoxicity detection based on DNA damage-induced gene expression. Radiol Oncol 2010; 44: 42-51.10.2478/v10019-010-0010-3
Search in Google Scholar
Cesar Paz-y-Mino, Perez CJ, Fiallo BF, Leone PE. A polymorphism in the hMSH2 gene (gIVS12-6T>C) associated with non-Hodgkin lymphomas. Cancer Genet Cytogenet 2002; 133: 29-33.10.1016/S0165-4608(01)00547-7
Search in Google Scholar
Worrillow LJ, Travis LB, Smith AG, Rollinson S, Smith AJ, Wild CP, et al. An intron splice acceptor polymorphism in hMSH2 and risk of leukemia after treatment with chemotherapeutic alkylating agents. Clin Cancer Res 2003; 9: 3012-20.
Search in Google Scholar
Ollila S, Delmadi Bebek D, Jiricny J, Nystrom M. Mechanisms of pathogenicity in human MSH2 missense mutants. Human Mutation 2008: 29: 1355-63.10.1002/humu.2089318951462
Search in Google Scholar

Genotyping of BRCA1, BRCA2, p53, CDKN2A, MLH1 and MSH2 genes in a male patient with secondary breast cancer

Abstract

Paradigm

My account